ABC | Volume 110, Nº5, May 2018

Original Article Odozynski et al Gender and AF ablation Arq Bras Cardiol. 2018; 110(5):449-454 1. Michelena HI, Powell BD, Brady PA, Friedman PA, Ezekowitz MD. Gender in atrial fibrillation: ten years later. Gend Med. 2010;7(3):206-17. doi: 10.1016/j.genm.2010.06.001. 2. Avgil Tsadok M, Gagnon J, Joza J, Behlouli H, Verma A, Essebag V, et al. Temporal trends and sex differences in pulmonary vein isolation for patients with atrial fibrillation. Heart Rhythm. 2015;12(9):1979-86. doi: 10.1016/j. hrthm.2015.06.029. 3. Kummer BR, Bhave PD, Merkler AE, Gialdini G, Okin PM, Kamel H. Demographic difference in catheter ablation after hospital presentation with symptomatic atrial fibrillation. J AmHeart Assoc. 2015;4(9):e002097. doi: 10.1161/JAHA.115.002097. 4. Patel N, DeshmukhA, Takkar B, Coffey JO, Agnihotri K, Patel A, et al. Gender, race, and health insurance status in patients undergoing catheter ablation for atrial fibrillation. Am J Cardiol. 2016;117(7):1117-26. doi: 10.1016/j. amjcard.2016.01.040. 5. Roten L, Rimoldi SF, Schwick N, Sakata T, Hemigartner C, Fuhrer J, et al. Gender differences in patients referred for atrial fibrillation management to am tertiary center. Pacing Clin Electrophysiol. 2009;32(5):622-6. doi: 10.1111/j.1540-8159.2009.02335.x. 6. Bertaglia E, Stabile G, Pappone A, Themistoclakis S, Tondo C, De Sanctis V, et al. Updated national multicenter registry on procedural safety of catheter ablation foratrial fibrillation. JCardiovascElectrophysiol. 2013;24(10):1069- 74. doi: 10.1111/jce.12194. 7. Zhang XD, Tan HW, Gu J, Jiang WF, Zhao L, Wang YL, et al. Efficacy and safety of catheter ablation for long-standing persistent atrial fibrillation in women. Pacing Clin Electrophysiol. 2013;36(10):1236-44. doi: 10.1111/ pace.12212. 8. Shoemaker MB, Muhammad R, Farrell M, Parvez B, White BW, Streur M, et al. Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation. Am J Cardiol. 2013;111(3):368-73. doi: 10.1016/j.amjcard.2012.10.013. 9. Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlattky MA. Procedural complications, re-hospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2012;59(2):143- 9. doi: 10.1016/j.jacc.2011.08.068. Erratum in: J Am Coll Cardiol. 2012;59(16):1492. 10. Michowitz Y, Rahkovich M, Oral H, Zado ES, Tilz R, John S, et al. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation. Circ ArrhythmElectrophysiol. 2014;7(2):274-80. doi: 10.1161/ CIRCEP.113.000760. 11. Forelo GB, Tondo C, De Luca L, Dello Russo A, Casella M, De Sanctis V, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace. 2007;9(8): 613-20. doi: https://doi.org/10.1093/europace/ eum144 12. Henry L, Hunt S, Holmes SD, Martin LM, AdN. Are there gender difference in outcomes after the Cox-Maze procedure for atrial fibrillation? Innovations (Phila). 2013;8(3):190-8. doi: 10.1097/IMI.0b013e3182a2306c. 13. Takigawa M, Kuwahara T, Takahashi A, Watari Y, Okubo K, Takahashi Y, et al. Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. Int J Cardiol. 2013;168(3):1984-91. doi: 10.1016/j. ijcard.2012.12.101. 14. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart RhythmAssociation (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia PacificHeart RhythmSociety, and theHeart RhythmSociety. Heart Rhythm. 2012;9(4):632-96.e21. doi: 10.1016/j.hrthm.2011.12.016. 15. DorianP,GuerraPG,KerrCR,O’DonnellSS,CrystalE,GillisAM,etal.Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale. Circ Arrhythm Electrophysiol. 2009;2(3):218-24. doi: 10.1161/CIRCEP.108.812347. 16. Singh SM, Avila AD, Aryana A, Kim Y, Mangrum JM, Michaud GF, et al. Persistent atrial fibrillation ablation in females : insight from the MAGIC-AF trial. J Cardiovasc Electrophysiol. 2016 Jul 27. doi: 10.1111/jce.13051. [Epub ahead of print]. 17. Rienstra M, Van Veldhuisen DJ, Hagens Vem Ranchor AV, Veeger NJ, Crijns HJ, et al; RACE Investigators. Gender-related differences in rhythm control treatment in persistent atrial fibrillation. J AmColl Cardiol. 2005;46(7):1298- 306. doi: https://doi.org/10.1016/j.jacc.2005.05.078. 18. Torp-Pedersen C, Moller M, Bloch-Thomsen PE, Kober L, Sandoe E, Egstrup K, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med. 1999;341(12):857-65. doi: 10.1056/NEJM199909163411201. 19. Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib S. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation. Circ ArrhythmElectrophysiol. 2009;2(6):626-33. doi: 10.1161/CIRCEP.109.856633. 20. Walter TE, The AW, Spence S, Morton JB, Kistler PM, Kalman JM. Absence of gender-based differences in the atrial and pulmonary vein substrate: a detailed electroanatomic mapping study. J Cardiovasc Electrophysiol. 2014;25(10):1065-70. doi: 10.1111/jce.12465. 21. Pfannmuller B, Boldt A, Reutermann A, Duerrschmidt N, Krabbes-Graube S, Mohr FW, et al. Gender-specific remodeling in atrial fibrillation? Thorac Cardiovasc Surg. 2013;61(1):66-73. doi: 10.1055/s-0032-1332795. 22. Nedios S, Kosiuk J, Koutalas E, Kornel J, Sommer P, Arya A, et al. Comparison of left atrial dimensions in CT and echocardiography as predictors of long-term success after catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2015;43(3):237-44. doi: 10.1007/s10840-015-0010-8. 23. Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Study. Circulation. 1995;92(4):835-841. doi: https://doi.org/10.1161/01.CIR.92.4.835. 24. Chieffo A, Buchanan GL, Mauri F, Mehilli K, Vaquerizo B, Moynagh A, et al. ACS and STEMI treatment: gender related issues. EuroIntervention. 2012;8 Suppl P:P27-35. doi: 10.4244/EIJV8SPA6. References 453